Korea advances regenerative medicine with new bioethics law implementation Korea enhances patient treatment options through ...

Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month ...

Dry Eye Syndrome Treatment Market Advancements in AI Diagnostics, Drug-Device Therapies, and Regenerative Medicine are Fueling Market Expan ...

Researchers from Tokyo Metropolitan University have developed a way to treat ageing-related muscular atrophy using ...

Gaudi Clinical, developing distribution infrastructure for regenerative medicine, announced on February 7th raising 1.35 billion yen through third-party allocation of shares led by JIC Venture ...

Researchers from Tokyo Metropolitan University have developed a way to treat age-related muscular atrophy using regenerative ...

The FDA granted Regenerative Medicine Advanced Therapy designation to NXC-201 for the treatment of relapsed/refractory light ...

Based on alignment gained with FDA under the Regenerative Medicine Advanced Therapy (RMAT) designation, Neurona plans to conduct the Phase 3 ...

At Regenity Biosciences, our focus is on making a material difference in the lives of patients by transforming bioresorbable materials into life- ...

Cyrano Therapeutics, Inc., a clinical-stage regenerative medicine company pioneering the development of treatments for smell loss, announced today that on February 14, 2025 it entered into an option ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which ...